Tardive Dyskinesia with Antipsychotic Medication in Children and Adolescents: A Systematic Literature Review

Frank M. C. Besag,Michael J. Vasey,Iffah Salim,Chris Hollis
DOI: https://doi.org/10.1007/s40264-024-01446-0
2024-06-13
Drug Safety
Abstract:Tardive dyskinesia (TD) is a persisting, and potentially irreversible, movement disorder associated with treatment with dopamine receptor antagonists. Few data are available on the risk of TD in children and adolescents treated with antipsychotic medication.
pharmacology & pharmacy,public, environmental & occupational health,toxicology
What problem does this paper attempt to address?